Revenues of leading global generics manufacturers 2023

With a revenue of 8.7 billion U.S. dollars, Teva was the global second leading drug manufacturer based on generics revenue in 2023. The first ranked company, Sandoz generated some 9.6 billion U.S. dollars that year. 

Generic prescription drugs

Worldwide generic prescription drug revenue is expected to increase in the coming years: the total amount of revenue generated in 2023 was estimated at 90 billion U.S. dollars and is projected to reach 100 billion U.S. dollars by 2026. Branded prescription medication generally generates the highest revenues: in the U.S., branded drug revenue amounts to some 80 to 85 percent of total revenues. 

Generic brands

A generic of a brand name drug lacks a widely recognized name. As a result, it tends to make them a cheaper alternative to the brand-name goods, as they are not usually advertised. Interestingly, generic drugs are sometimes created by the same manufacturers that create branded drugs.